3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Skin Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul-Karim, FW; Fu, W; Gibbons, HE; Gorodeski, GI; Li, X; Luo, L; McCormick, T; Qi, X; Wang, BC; Zhou, L | 1 |
1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Skin Neoplasms
| Article | Year |
|---|---|
Activation of P2X(7)-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenosine Triphosphate; Animals; Apoptosis; Blotting, Western; Calcium; Caspase 3; Caspase 9; Caspase Inhibitors; Cells, Cultured; Dose-Response Relationship, Drug; Female; Immunohistochemistry; In Situ Nick-End Labeling; Keratinocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligopeptides; Papilloma; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Survival Analysis; Tetradecanoylphorbol Acetate | 2009 |